OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Host B7x Promotes Pulmonary Metastasis of Breast Cancer
Yael M. Abadi, Hyungjun Jeon, Kim C. Ohaegbulam, et al.
The Journal of Immunology (2013) Vol. 190, Iss. 7, pp. 3806-3814
Open Access | Times Cited: 68
Yael M. Abadi, Hyungjun Jeon, Kim C. Ohaegbulam, et al.
The Journal of Immunology (2013) Vol. 190, Iss. 7, pp. 3806-3814
Open Access | Times Cited: 68
Showing 1-25 of 68 citing articles:
Combination cancer immunotherapies tailored to the tumour microenvironment
Mark J. Smyth, Shin Foong Ngiow, Antoni Ribas, et al.
Nature Reviews Clinical Oncology (2015) Vol. 13, Iss. 3, pp. 143-158
Closed Access | Times Cited: 844
Mark J. Smyth, Shin Foong Ngiow, Antoni Ribas, et al.
Nature Reviews Clinical Oncology (2015) Vol. 13, Iss. 3, pp. 143-158
Closed Access | Times Cited: 844
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
Frank A. Schildberg, Sarah R. Klein, Gordon J. Freeman, et al.
Immunity (2016) Vol. 44, Iss. 5, pp. 955-972
Open Access | Times Cited: 500
Frank A. Schildberg, Sarah R. Klein, Gordon J. Freeman, et al.
Immunity (2016) Vol. 44, Iss. 5, pp. 955-972
Open Access | Times Cited: 500
Organotropism: new insights into molecular mechanisms of breast cancer metastasis
Wenjing Chen, Andrew D. Hoffmann, Huiping Liu, et al.
npj Precision Oncology (2018) Vol. 2, Iss. 1
Open Access | Times Cited: 309
Wenjing Chen, Andrew D. Hoffmann, Huiping Liu, et al.
npj Precision Oncology (2018) Vol. 2, Iss. 1
Open Access | Times Cited: 309
The third group of the B7‐CD 28 immune checkpoint family: HHLA 2, TMIGD 2, B7x, and B7‐H3
Murali Janakiram, Urvi A. Shah, Weifeng Liu, et al.
Immunological Reviews (2017) Vol. 276, Iss. 1, pp. 26-39
Open Access | Times Cited: 201
Murali Janakiram, Urvi A. Shah, Weifeng Liu, et al.
Immunological Reviews (2017) Vol. 276, Iss. 1, pp. 26-39
Open Access | Times Cited: 201
HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function
Ruihua Zhao, Jordan M. Chinai, Susan Buhl, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 110, Iss. 24, pp. 9879-9884
Open Access | Times Cited: 188
Ruihua Zhao, Jordan M. Chinai, Susan Buhl, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 110, Iss. 24, pp. 9879-9884
Open Access | Times Cited: 188
Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein
Murali Janakiram, Jordan M. Chinai, Susan Fineberg, et al.
Clinical Cancer Research (2014) Vol. 21, Iss. 10, pp. 2359-2366
Open Access | Times Cited: 140
Murali Janakiram, Jordan M. Chinai, Susan Fineberg, et al.
Clinical Cancer Research (2014) Vol. 21, Iss. 10, pp. 2359-2366
Open Access | Times Cited: 140
New checkpoints in cancer immunotherapy
Ling Ni, Chen Dong
Immunological Reviews (2017) Vol. 276, Iss. 1, pp. 52-65
Closed Access | Times Cited: 129
Ling Ni, Chen Dong
Immunological Reviews (2017) Vol. 276, Iss. 1, pp. 52-65
Closed Access | Times Cited: 129
Advanced Role of Neutrophils in Common Respiratory Diseases
Jinping Liu, Zhiqiang Pang, Guoqiang Wang, et al.
Journal of Immunology Research (2017) Vol. 2017, pp. 1-21
Open Access | Times Cited: 93
Jinping Liu, Zhiqiang Pang, Guoqiang Wang, et al.
Journal of Immunology Research (2017) Vol. 2017, pp. 1-21
Open Access | Times Cited: 93
B7-H4, a promising target for immunotherapy
Jiayu Wang, Weipeng Wang
Cellular Immunology (2019) Vol. 347, pp. 104008-104008
Closed Access | Times Cited: 76
Jiayu Wang, Weipeng Wang
Cellular Immunology (2019) Vol. 347, pp. 104008-104008
Closed Access | Times Cited: 76
Interferon-γ in the tumor microenvironment promotes the expression of B7H4 in colorectal cancer cells, thereby inhibiting cytotoxic T cells
Zhi-Liang Jing, Guang‐long Liu, Na Zhou, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Zhi-Liang Jing, Guang‐long Liu, Na Zhou, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
The CD28-B7 Family in Anti-Tumor Immunity: Emerging Concepts in Cancer Immunotherapy
Joanne Leung, Woong‐Kyung Suh
Immune Network (2014) Vol. 14, Iss. 6, pp. 265-265
Open Access | Times Cited: 85
Joanne Leung, Woong‐Kyung Suh
Immune Network (2014) Vol. 14, Iss. 6, pp. 265-265
Open Access | Times Cited: 85
Mechanism of immune evasion in breast cancer
Mozhi Wang, Changwang Zhang, Yongxi Song, et al.
OncoTargets and Therapy (2017) Vol. Volume 10, pp. 1561-1573
Open Access | Times Cited: 81
Mozhi Wang, Changwang Zhang, Yongxi Song, et al.
OncoTargets and Therapy (2017) Vol. Volume 10, pp. 1561-1573
Open Access | Times Cited: 81
Structure and Cancer Immunotherapy of the B7 Family Member B7x
Hyungjun Jeon, В. И. Вигдорович, Sarah C. Garrett-Thomson, et al.
Cell Reports (2014) Vol. 9, Iss. 3, pp. 1089-1098
Open Access | Times Cited: 67
Hyungjun Jeon, В. И. Вигдорович, Sarah C. Garrett-Thomson, et al.
Cell Reports (2014) Vol. 9, Iss. 3, pp. 1089-1098
Open Access | Times Cited: 67
Immune checkpoint blockade and its combination therapy with small-molecule inhibitors for cancer treatment
Manni Wang, Yu Liu, Yuan Cheng, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2019) Vol. 1871, Iss. 2, pp. 199-224
Open Access | Times Cited: 57
Manni Wang, Yu Liu, Yuan Cheng, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2019) Vol. 1871, Iss. 2, pp. 199-224
Open Access | Times Cited: 57
Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody–Drug Conjugate for the Treatment of Cancer
Dorin Toader, Shawn P. Fessler, Scott D. Collins, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 9, pp. 999-1012
Open Access | Times Cited: 18
Dorin Toader, Shawn P. Fessler, Scott D. Collins, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 9, pp. 999-1012
Open Access | Times Cited: 18
Emerging roles of regulatory T cells in tumour progression and metastasis
Elizabeth C. Halvorsen, Sahar Mahmoud, Kevin L. Bennewith
Cancer and Metastasis Reviews (2014) Vol. 33, Iss. 4, pp. 1025-1041
Closed Access | Times Cited: 65
Elizabeth C. Halvorsen, Sahar Mahmoud, Kevin L. Bennewith
Cancer and Metastasis Reviews (2014) Vol. 33, Iss. 4, pp. 1025-1041
Closed Access | Times Cited: 65
An Anti-B7-H4 Antibody–Drug Conjugate for the Treatment of Breast Cancer
Steven R. Leong, Wei‐Ching Liang, Yan Wu, et al.
Molecular Pharmaceutics (2015) Vol. 12, Iss. 6, pp. 1717-1729
Closed Access | Times Cited: 57
Steven R. Leong, Wei‐Ching Liang, Yan Wu, et al.
Molecular Pharmaceutics (2015) Vol. 12, Iss. 6, pp. 1717-1729
Closed Access | Times Cited: 57
B7-H4 as a potential target for immunotherapy for gynecologic cancers: A closer look
Jenessa B. Smith, Caitlin Stashwick, Daniel J. Powell
Gynecologic Oncology (2014) Vol. 134, Iss. 1, pp. 181-189
Open Access | Times Cited: 56
Jenessa B. Smith, Caitlin Stashwick, Daniel J. Powell
Gynecologic Oncology (2014) Vol. 134, Iss. 1, pp. 181-189
Open Access | Times Cited: 56
Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target
Heather MacGregor, Pamela S. Ohashi
Clinical Cancer Research (2017) Vol. 23, Iss. 12, pp. 2934-2941
Open Access | Times Cited: 55
Heather MacGregor, Pamela S. Ohashi
Clinical Cancer Research (2017) Vol. 23, Iss. 12, pp. 2934-2941
Open Access | Times Cited: 55
Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy
Jenessa B. Smith, Evripidis Lanitis, Denarda Dangaj, et al.
Molecular Therapy (2016) Vol. 24, Iss. 11, pp. 1987-1999
Open Access | Times Cited: 52
Jenessa B. Smith, Evripidis Lanitis, Denarda Dangaj, et al.
Molecular Therapy (2016) Vol. 24, Iss. 11, pp. 1987-1999
Open Access | Times Cited: 52
Higher preoperative serum levels of PD ‐L1 and B7‐H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF ‐targeted therapy and unfavorable prognosis of renal cell carcinoma
Takehiko Fukuda, Takao Kamai, Akinori Masuda, et al.
Cancer Medicine (2016) Vol. 5, Iss. 8, pp. 1810-1820
Open Access | Times Cited: 48
Takehiko Fukuda, Takao Kamai, Akinori Masuda, et al.
Cancer Medicine (2016) Vol. 5, Iss. 8, pp. 1810-1820
Open Access | Times Cited: 48
The B7x Immune Checkpoint Pathway: From Discovery to Clinical Trial
Peter John, Wei Yao, Weifeng Liu, et al.
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 11, pp. 883-896
Open Access | Times Cited: 46
Peter John, Wei Yao, Weifeng Liu, et al.
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 11, pp. 883-896
Open Access | Times Cited: 46
B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
Ling Wang, Chao Yang, Xinbo Liu, et al.
Cancer Cell International (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 41
Ling Wang, Chao Yang, Xinbo Liu, et al.
Cancer Cell International (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 41
B7-H4 Modulates Regulatory CD4+ T Cell Induction and Function via Ligation of a Semaphorin 3a/Plexin A4/Neuropilin-1 Complex
Joseph R. Podojil, Ming-Yi Chiang, Igal Ifergan, et al.
The Journal of Immunology (2018) Vol. 201, Iss. 3, pp. 897-907
Open Access | Times Cited: 38
Joseph R. Podojil, Ming-Yi Chiang, Igal Ifergan, et al.
The Journal of Immunology (2018) Vol. 201, Iss. 3, pp. 897-907
Open Access | Times Cited: 38
Novel B7-H4-mediated crosstalk between human non-Hodgkin lymphoma cells and tumor-associated macrophages leads to immune evasion via secretion of IL-6 and IL-10
Fengyuan Che, Xueyuan Heng, Haiyan Zhang, et al.
Cancer Immunology Immunotherapy (2017) Vol. 66, Iss. 6, pp. 717-729
Closed Access | Times Cited: 35
Fengyuan Che, Xueyuan Heng, Haiyan Zhang, et al.
Cancer Immunology Immunotherapy (2017) Vol. 66, Iss. 6, pp. 717-729
Closed Access | Times Cited: 35
